CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
reSET-O appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04129580
NCT04129580N/ACompleted
CompareCT.gov

A Randomized Clinical Trial of Comprehensive Cognitive Behavioral Therapy (CBT) Via reSET-O for a Hub and Spoke Medication Assisted Treatment (MAT) System of Care.

Milton S. Hershey Medical Center·interventional·Posted Oct 17, 2019·Updated Nov 20, 2024

In Brief

A clinical study evaluating reSET-O app for Opioid-use Disorder. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use disorder after initiating medication assisted treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-use Disorder
CountriesUnited States
CollaboratorsColumbia University, Pear Therapeutics, Inc., National Institutes of Health (NIH), Research Foundation for Mental Hygiene, Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 17, 2019
Enrollment StartSep 15, 2020
Primary CompletionJul 14, 2023
Study CompletionSep 19, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.7 years ago

Interventions

reSET-O appdevice

The reSET-O app, owned by Pear Therapeutics, Inc., is designed to work as cognitive behavioral therapy, adjunctive to medication assisted treatment, for opioid use disorder. The app provides psychoeducation related to opioid use and dependence, coping skills, and skills to avoid relapse,